✦ LIBER ✦

5088 Analysis of factors predicting response to second-line trastuzumab- based therapy in patients (pts) with Her2-positive advanced breast cancer (ABC)

✍ Scribed by R. Bartsch; C. DeVries; U. Pluschnig; P. Dubsky; S. Horvath; M. Rudas; R.M. Mader; M. Gnant; C.C. Zielinski; G.G. Steger

Book ID: 119600738
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(09)70980-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting for activity of second-line t

Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer

✍ Rupert Bartsch; Catharina De Vries; Ursula Pluschnig; Peter Dubsky; Zsuzsanna Ba 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 644 KB

Analysis of factors predicting response

Analysis of factors predicting response to first line endocrine therapy (HT) in menopausal patients with luminal-type advanced breast cancer (ABC)

✍ Olexiy Aseyev 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Trastuzumab Emtansine: A Review of Its U

Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy

✍ Dhillon, Sohita 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 402 KB

Hormone-receptor status and likelihood o

Hormone-receptor status and likelihood of predicting pathological complete response (pCR) in the NOAH trial of neoadjuvant trastuzumab in patients (pts) with HER2-positive locally advanced breast cancer (LABC)

✍ W. Eiermann; J. Baselga; V. Semiglazov; M. Byakhov; E. Ciruelos; B. Ojeda; A. Fe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase Ib Study of Buparlisib plus Trastu

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

✍ Saura, C.; Bendell, J.; Jerusalem, G.; Su, S.; Ru, Q.; De Buck, S.; Mills, D.; R 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 898 KB

The combination of letrozole and trastuz

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

✍ P. Kelly Marcom; Claudine Isaacs; Lyndsay Harris; Zee Wang Wong; Aruna Kommarred 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 144 KB